| 标题 |
Activation of MET signaling by HDAC6 offers a rationale for a novel ricolinostat and crizotinib combinatorial therapeutic strategy in diffuse large B‐cell lymphoma |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Journal of Pathology 作者:Zebing Liu; Ying Cai; Yu Yang; Anqi Li; Rui Bi; et al 出版日期:2018-06-07 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)